- Home
- FHTX vs NODK Comparison
FHTX vs NODK Comparison
Compare FHTX & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- NODK
- Stock Information
- Founded
- FHTX 2015
- NODK 1946
- Country
- FHTX United States
- NODK United States
- Employees
- FHTX N/A
- NODK N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- NODK Property-Casualty Insurers
- Sector
- FHTX Health Care
- NODK Finance
- Exchange
- FHTX Nasdaq
- NODK Nasdaq
- Market Cap
- FHTX 278.1M
- NODK 289.0M
- IPO Year
- FHTX 2020
- NODK 2017
- Fundamental
- Price
- FHTX $4.23
- NODK $13.21
- Analyst Decision
- FHTX Strong Buy
- NODK
- Analyst Count
- FHTX 5
- NODK 0
- Target Price
- FHTX $11.80
- NODK N/A
- AVG Volume (30 Days)
- FHTX 270.7K
- NODK 9.5K
- Earning Date
- FHTX 10-31-2025
- NODK 11-05-2025
- Dividend Yield
- FHTX N/A
- NODK N/A
- EPS Growth
- FHTX N/A
- NODK N/A
- EPS
- FHTX N/A
- NODK 0.07
- Revenue
- FHTX $24,173,000.00
- NODK $310,389,000.00
- Revenue This Year
- FHTX $42.43
- NODK N/A
- Revenue Next Year
- FHTX $14.77
- NODK N/A
- P/E Ratio
- FHTX N/A
- NODK $187.45
- Revenue Growth
- FHTX N/A
- NODK N/A
- 52 Week Low
- FHTX $2.95
- NODK $12.01
- 52 Week High
- FHTX $9.70
- NODK $17.24
- Technical
- Relative Strength Index (RSI)
- FHTX 45.28
- NODK 44.85
- Support Level
- FHTX $3.85
- NODK $13.16
- Resistance Level
- FHTX $4.69
- NODK $13.80
- Average True Range (ATR)
- FHTX 0.33
- NODK 0.20
- MACD
- FHTX 0.04
- NODK -0.03
- Stochastic Oscillator
- FHTX 55.77
- NODK 24.41
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.